Alpha BreakingAlpha Breaking
Bearish Sentiment

Warburg Pincus Sells $2897Mm in Sotera Health - May 15

2 min read|Friday, May 15, 2026 at 6:03 PM ET
Warburg Pincus Sells $2897Mm in Sotera Health - May 15

Share this article

Spread the word on social media

The Story

Private equity firm Warburg Pincus completed $289.7m in sales of Sotera Health stock, according to a filing reported by Investing.com. The filing lists figures including 33.83%, 15.68% and 0.81%, and investors should watch how the market prices $SHC shares following the move.

Why It Matters For Your Portfolio

  • $289.7m sale size, reported by Investing.com, increases available float and could pressure $SHC share price if demand does not absorb the supply.
  • The filing includes 33.83%, a material percentage noted in the report, which investors can use when re-running ownership and valuation models for $SHC.
  • The filing also lists 15.68%, a reported figure that may reflect a portion of stake or dilution metrics useful for portfolio position sizing.
  • The 0.81% figure in the filing, as reported, is a small but measurable number that can affect short-term liquidity and technical support levels for $SHC.

The Trade

This is relevant for traders and risk-conscious equity investors who track insider and sponsor exits, and for anyone using ownership data in valuation models. Monitor follow-up filings and any additional secondary offerings, plus $SHC trading volume and upcoming company disclosures as the next catalysts to watch.

Warburg Pincus sells $289.7m in Sotera Health (SHC) stockSotera Health saleSHC stockWarburg Pincus saleinsider selling

Trade this headline in Alpha Contests.

Free practice contests — earn Alpha Coins
Enter a Contest

Stay Ahead of the Market

Get breaking news on trending finance topics delivered as they happen. We find the stories others miss.

More Breaking News

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.